Wedbush analyst Daniel Ives lowered the firm’s price target on DocuSign (DOCU) to $75 from $85 and keeps a Neutral rating on the shares. The firm notes the company reported its Q3 results featuring beats across the board as the company saw strong demand for IAM and eSignature, but the performance will be overshadowed by the relatively conservative outlook.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign Hold Rating: Balancing Strong Performance with Growth Concerns
- DocuSign price target lowered to $75 from $90 at Baird
- DocuSign price target lowered to $82 from $102 at BofA
- DocuSign price target lowered to $75 from $85 at Wells Fargo
- Optimistic Outlook for DocuSign: Strong Q3 Performance and Strategic Shifts Drive Buy Rating